Amy A Lo
8PUBLICATIONS
63CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 06, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.Juanita Lopez, Thomas Powles, Fadi Braiteh
|Oct 04, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors.Christopher J Sweeney, John D Hainsworth, Ron Bose
|Jan 09, 2023
T cell-dependent bispecific antibodies alter organ-specific endothelial cell-T cell interaction.Patricia Himmels, Thi Thu Thao Nguyen, Maresa Caunt Mitzner
|Apr 01, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer.Peiyin Wang, Liping L Sun, Robyn Clark
|Mar 17, 2022
Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma.Andrew Wallace, Sima P Porten, Amy A Lo
|Oct 02, 2021
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies.Amy A Lo, Andrew Wallace, Daniel Oreper
Pageof 2
Frequent Collaborators
4 joint publications
Robyn Clark
3 joint publications
Diego Ellerman
2 joint publications
Christoph Spiess
2 joint publications
Robert Piskol
2 joint publications
Oliver A Zill
1 joint publications
Dionysos Slaga
1 joint publications
T Noelle Lombana
1 joint publications
Ugur Sahin
1 joint publications
Ji Li
1 joint publications
Jennifer Johnston
